- KY02111
-
- $35.00 / 10mg
-
2024-11-19
- CAS:1118807-13-8
- Min. Order:
- Purity: 98.68%
- Supply Ability: 10g
|
| Product Name: | KY0211 | | Synonyms: | KY0211;KY02111;KY02111 / KY-02111;N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide;KY02111, >=98%;Benzenepropanamide, N-(6-chloro-2-benzothiazolyl)-3,4-dimethoxy-;KY0211 N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide;N-(6-Chloro-2-benzothiazolyl)-3,4-dimethoxybenzenepropanamide KY02111 | | CAS: | 1118807-13-8 | | MF: | C18H17ClN2O3S | | MW: | 376.86 | | EINECS: | 808-505-5 | | Product Categories: | Inhibitors;API | | Mol File: | 1118807-13-8.mol |  |
| | KY0211 Chemical Properties |
| density | 1.362±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: soluble10mg/mL, clear | | pka | 9.92±0.70(Predicted) | | form | powder | | color | white to beige | | Stability: | Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20° for up to 3 months. |
| Hazard Codes | Xn | | Risk Statements | 22 | | Safety Statements | 46 | | WGK Germany | 3 |
| | KY0211 Usage And Synthesis |
| Description | KY-02111 (1118807-13-8) promotes cardiac differentiation of human pluripotent stem cells. Inhibits Wnt signaling in a manner that appears to be distinct from previously described Wnt inhibitors.1 Cell permeable and active in vivo. | | Uses | KY 0211, allows for inducing differentiation of pluripotent stem cell into cardiac muscle. | | storage | +4°C | | References | 1) Minami et al. (2012), A small molecule that promotes cardiac differentiation of human pluripotent stem cells under defined, cytokine- and xeno-free conditions; Cell Rep., 2 1448 |
| | KY0211 Preparation Products And Raw materials |
|